Sight Sciences, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 4, 2026, reports on the results of the Annual Meeting of Stockholders held by Sight Sciences, Inc. on that date. The Company is incorporated in Delaware and its common stock trades on the Nasdaq Global Select Market under the symbol SGHT.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
At the Annual Meeting, 41,456,258 shares were present or represented by proxy, representing approximately 76.2% of the 54,403,542 shares outstanding on the record date of April 8, 2026. Two proposals were voted upon:
- Proposal 1 (Election of Directors): Gerhard Burbach and Staffan Encrantz were elected as Class II directors to serve until the 2029 annual meeting.
- Gerhard Burbach: 24,961,185 votes For; 2,877,580 votes Withheld.
- Staffan Encrantz: 23,901,624 votes For; 3,937,141 votes Withheld.
- Proposal 2 (Ratification of Auditors): The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified.
- For: 41,059,471 votes
- Against: 7,892 votes
- Abstain: 388,895 votes
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. No other matters were presented for stockholder action.
Key Facts for Investor Verification
- Confirmation of the new Class II directors' tenure through 2029.
- Verification of the auditor appointment for the fiscal year ending December 31, 2026.
- Review of the definitive proxy statement (Schedule 14A) filed on April 22, 2026, for detailed background on the proposals.
- Confirmation of the 76.2% shareholder participation rate at the Annual Meeting.